Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
In this work, hybrid compounds <b>1</b>−<b>4</b> obtained by conjugation of the non-steroidal anti-inflammatory drug diclofenac, with natural molecules endowed with antioxidant and antiproliferative activity were prepared. The antiproliferative activity of these hyb...
Main Authors: | Silvia Tampucci, Sara Carpi, Maria Digiacomo, Beatrice Polini, Stefano Fogli, Susi Burgalassi, Marco Macchia, Paola Nieri, Clementina Manera, Daniela Monti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/9/1793 |
Similar Items
-
Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
by: Katrin Singer, et al.
Published: (2019-07-01) -
Tirbanibulin as a Novel Treatment in Actinic Keratosis: A Literature Review
by: Ilona Sajkiewicz, et al.
Published: (2024-09-01) -
Pharmacological treatment of actinic keratosis
by: Ewa Zwierzyńska, et al.
Published: (2016-09-01) -
Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies
by: Jan Kehrmann, et al.
Published: (2023-06-01) -
Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid
by: Gamze Ozturk Karabulut, et al.
Published: (2017-05-01)